These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8290528)

  • 1. [Erythrocyte metabolism during chemotherapy in pulmonary tuberculosis patients].
    Kaminskaia GO; Abdullaev RIu
    Probl Tuberk; 1993; (6):32-5. PubMed ID: 8290528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Red blood cell metabolic changes in patients with acutely progressive pulmonary tuberculosis].
    Kaminskaia GO; Abdullaev RIu
    Probl Tuberk; 2002; (2):33-6. PubMed ID: 11899803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antioxidant treatment of pulmonary tuberculosis in patients with chronic alcoholism].
    Burnusus ZI
    Probl Tuberk; 1992; (5-6):28-30. PubMed ID: 1409509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma antioxidative activity in patients with pulmonary tuberculosis].
    Kowalski J; Janiszewska-Drobińska B; Pawlicki L; Cegliński T; Irzmański R
    Pol Merkur Lekarski; 2004 Feb; 16(92):119-22. PubMed ID: 15176293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of antimicrobial chemotherapy and smoking status on the plasma concentrations of vitamin C, vitamin E, beta-carotene, acute phase reactants, iron and lipid peroxides in patients with pulmonary tuberculosis.
    Plit ML; Theron AJ; Fickl H; van Rensburg CE; Pendel S; Anderson R
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):590-6. PubMed ID: 9661828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of lidase in the treatment of patients with fibro-cavernous pulmonary tuberculosis].
    Grigaliunas AP
    Probl Tuberk; 1974; (11):26-30. PubMed ID: 4449837
    [No Abstract]   [Full Text] [Related]  

  • 7. [Opportunities for the evaluation of the secondary reaction of antituberculosis drugs by several indicators, determined in the blood of patients with tuberculosis of the lungs].
    Khomenko AG; Vysochina IV; Kolosovskaia VP; Efimova LN; Kuz'mina NV
    Vopr Med Khim; 1983; 29(3):83-8. PubMed ID: 6880125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis.
    Giosuè S; Casarini M; Ameglio F; Zangrilli P; Palla M; Altieri AM; Bisetti A
    Eur Cytokine Netw; 2000 Mar; 11(1):99-104. PubMed ID: 10705306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The metabolic correction of erythrocyte function in patients with pulmonary tuberculosis complicated by pulmonary heart failure].
    Khomenko AG; Kryzhanovskiĭ DG; Kaminskaia GO; Serebrianaia BA; Balta NG
    Ter Arkh; 1990; 62(9):25-9. PubMed ID: 2126395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antioxidant effectiveness in preventing and eliminating the side effects of antibacterial preparations in pulmonary tuberculosis patients].
    Starostenko EV; Andrzheiuk NI; Salpagarov AM
    Probl Tuberk; 1987; (10):34-7. PubMed ID: 3422950
    [No Abstract]   [Full Text] [Related]  

  • 11. [Red cell system and selected red cell enzymes in men occupationally exposed to mercury vapours].
    Zabiński Z; Rutowski J; Moszczyński P; Dabrowski Z
    Przegl Lek; 2006; 63 Suppl 7():74-83. PubMed ID: 17784549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of soluble ozone in combined treatment of pulmonary tuberculosis: lipid peroxidation and blood antioxidative defense systems].
    Belianin II; Abdullaev RIu
    Probl Tuberk; 2000; (3):41-4. PubMed ID: 10900985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of chemotherapy in combination with Marepomiel on the content of trace and macroelements in patients with pulmonary tuberculosis].
    Baburina EA
    Probl Tuberk; 1997; (5):26-7. PubMed ID: 9454245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver function tests in patients of pulmonary tuberculosis using four different drug regimens.
    Akbri MZ; Fatima N; ul Haque E; Shiekh AS; Bhatti MS
    J Ayub Med Coll Abbottabad; 2001; 13(2):5-10. PubMed ID: 11732224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The cytogenic status of peripheral lymphocytes in pulmonary tuberculosis before and during chemotherapy].
    Novitskiĭ VV; Strelis AK; Urazova OI; Luk'ianova TA; Riabova EA; Esimova IE; Voronkova OV; Sinitsyna VA; Filiniuk OV; Zemlianaia NA
    Probl Tuberk Bolezn Legk; 2005; (5):43-6. PubMed ID: 15988978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of drug-induced hyperuricaemia on renal function in Nigerians with pulmonary tuberculosis.
    Adebisi SA; Oluboyo PO; Okesina AB
    Afr J Med Med Sci; 2000; 29(3-4):297-300. PubMed ID: 11714010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The study of the antioxidant enzymes in erythrocytes in lung diseases].
    Matskevich GN; Korotkina RN; Devlikanova ASh; Vishnevskiĭ AA; Karelin AA
    Patol Fiziol Eksp Ter; 2003; (2):23-5. PubMed ID: 12838770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy of destructive pulmonary tuberculosis with antioxidants and antihypoxic agents].
    Savula MM; Kravchenko NS; Poznanskiĭ AI
    Probl Tuberk; 1993; (5):18-20. PubMed ID: 8295877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of lymphotropic therapy in patients with tuberculosis in relations to genetic markers].
    Ubaĭdullaev AM; Belotserkovets VG; Kazakov KS
    Probl Tuberk; 2000; (6):44-6. PubMed ID: 11210834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.